Literature DB >> 11534257

Hughes (antiphospholipid) syndrome. Clinical features.

M J Cuadrado1, G R Hughes.   

Abstract

Hughes (antiphospholipid) syndrome is a noninflammatory autoimmune disease. The most critical pathologic process is thrombosis, which results in most of the clinical features suffered by these patients. Recurrent thrombosis together with an adverse pregnancy history and the presence of antiphospholipid antibodies defines the syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11534257     DOI: 10.1016/s0889-857x(05)70217-9

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  5 in total

Review 1.  Antiphospholipid syndrome: multiple mechanisms.

Authors:  C G Mackworth-Young
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

2.  Prevalence and Resolution of Lupus Anticoagulant in Children.

Authors:  Chandra Kallanagowdar; Aman Chauhan; Mora V Puertolas; Rajasekharan Warrier
Journal:  Ochsner J       Date:  2016

3.  Nocardiosis in a patient with primary anti-phospholipid syndrome.

Authors:  Mehmet Soy; Müşerref Tatman Oktun; Nermin Tunçbilek; Nilay Ermantaş; Omür Okten; Gündeniz Altinay; Burhan Turgut
Journal:  Rheumatol Int       Date:  2006-01-10       Impact factor: 2.631

4.  Lupus anticoagulant-hypoprothrombinemia in healthy adult.

Authors:  Choon Hae Chung; Chi Young Park
Journal:  Korean J Intern Med       Date:  2008-09       Impact factor: 2.884

5.  Antiphospholipid antibodies and systemic scleroderma.

Authors:  Awa Oumar Touré; Fatimata Ly; Abibatou Sall; Alassane Diatta; Macoura Gadji; Moussa Seck; Blaise Faye; Tandakha Dieye; Saliou Diop
Journal:  Turk J Haematol       Date:  2013-03-05       Impact factor: 1.831

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.